Inhibition of Osteolytic Bone Lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (a.p.d.)
Year: 1979
Type: article
Study design: Clinical Trial
Source: The Lancet
Institution: Leiden University Medical Center
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2083334726
